Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment

FASEB Journal

Volumn 24, Issue 3, 2010, Pages 788-798

  Murikinati, Sasidhar ^a   Jüttler, Eric ^a,f   Keinert, Timo ^a   Ridder, Dirk A ^a   Muhammad, Sajjad ^a   Waibler, Zoe ^b   Ledent, Catherine ^c   Zimmer, Andreas ^d   Kalinke, Ulrich ^e   Schwaninger, Markus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d UNIVERSITY OF BONN   (Germany)

^e INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bone marrow transplantation; Chemotaxis; p38; Stroke

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; CANNABINOID 2 RECEPTOR; MYELOPEROXIDASE; 1,1 DIMETHYLBUTYL 1 DEOXY DELTA(9) THC; 1,1-DIMETHYLBUTYL-1-DEOXY-DELTA(9)-THC; CANNABINOID; CXCL2 CHEMOKINE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE MARROW CELL; BRAIN ISCHEMIA; BRAIN PROTECTION; CEREBROVASCULAR ACCIDENT; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION INHIBITION; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROMODULATION; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BONE MARROW TRANSPLANTATION; BRAIN; CELL ADHESION; CELL LINE; CELL MOTION; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; FLOW CYTOMETRY; GENETICS; IMMUNOBLOTTING; MALE; METABOLISM; PHYSIOLOGY;

MUS;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; BRAIN; BRAIN ISCHEMIA; CANNABINOIDS; CELL ADHESION; CELL LINE; CELL MOVEMENT; CHEMOKINE CXCL2; ENDOTHELIAL CELLS; FLOW CYTOMETRY; IMMUNOBLOTTING; INTERLEUKIN-1BETA; MALE; MICE; NEUTROPHILS; RECEPTOR, CANNABINOID, CB2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952302634     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-141275     Document Type: Article

References (64)

1. Pacher, P., and Hasko, G. (2008) Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. Br. J. Pharmacol. 153, 252-262
2. Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., Mechoulam, R., and Pertwee, R. G. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54, 161-202
3. Brown, A. J. (2007) Novel cannabinoid receptors. Br. J. Pharmacol. 152, 567-575
4. Johns, D. G., Behm, D. J., Walker, D. J., Ao, Z., Shapland, E. M., Daniels, D. A., Riddick, M., Dowell, S., Staton, P. C., Green, P., Shabon, U., Bao, W., Aiyar, N., Yue, T. L., Brown, A. J., Morrison, A. D., and Douglas, S. A. (2007) The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. Br. J. Pharmacol. 152, 825-831
5. Jüttler, E., Potrovita, I., Tarabin, V., Prinz, S., Dong-Si, T., Fink, G., and Schwaninger, M. (2004) The cannabinoid dexanabinol is an inhibitor of the nuclear factor-kappaB (NF-κB). Neuropharmacology 47, 580-592
6. Hillard, C. J. (2008) Role of cannabinoids and endocannabinoids in cerebral ischemia. Curr. Pharm. Des. 14, 2347-2361
7. Parmentier-Batteur, S., Jin, K., Mao, X. O., Xie, L., and Greenberg, D. A. (2002) Increased severity of stroke in CB1 cannabinoid receptor knock-out mice. J. Neurosci. 22, 9771-9775 (Pubitemid 35332860)
8. Muthian, S., Rademacher, D. J., Roelke, C. T., Gross, G. J., and Hillard, C. J. (2004) Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. Neuroscience 129, 743-750
9. Berger, C., Schmid, P. C., Schabitz, W. R., Wolf, M., Schwab, S., and Schmid, H. H. (2004) Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia? J. Neurochem. 88, 1159-1167
10. Zhang, M., Martin, B. R., Adler, M. W., Razdan, R. K., Jallo, J. I., and Tuma, R. F. (2007) Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model. J. Cereb. Blood Flow Metab. 27, 1387-1396
11. Maresz, K., Pryce, G., Ponomarev, E. D., Marsicano, G., Croxford, J. L., Shriver, L. P., Ledent, C., Cheng, X., Carrier, E. J., Mann, M. K., Giovannoni, G., Pertwee, R. G., Yamamura, T., Buckley, N. E., Hillard, C. J., Lutz, B., Baker, D., and Dittel, B. N. (2007) Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB(1) on neurons and CB(2) on autoreactive T cells. Nat. Med. 13, 492-497
12. Kim, K., Moore, D. H., Makriyannis, A., and Abood, M. E. (2006) AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis. Eur. J. Pharmacol. 542, 100-105
13. Ramirez, B. G., Blazquez, C., del Pulgar, T. G., Guzman, M., and de Ceballos, M. L. (2005) Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J. Neurosci. 25, 1904-1913
14. Viscomi, M. T., Oddi, S., Latini, L., Pasquariello, N., Florenzano, F., Bernardi, G., Molinari, M., and Maccarrone, M. (2009) Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway. J. Neurosci. 29, 4564-4570
15. Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., Marnett, L. J., Di Marzo, V., Pittman, Q. J., Patel, K. D., and Sharkey, K. A. (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310, 329-332
16. Golech, S. A., McCarron, R. M., Chen, Y., Bembry, J., Lenz, F., Mechoulam, R., Shohami, E., and Spatz, M. (2004) Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Brain Res. Mol. Brain. Res. 132, 87-92
17. Blazquez, C., Casanova, M. L., Planas, A., Gomez Del Pulgar, T., Villanueva, C., Fernandez-Acenero, M. J., Aragones, J., Huffman, J. W., Jorcano, J. L., and Guzman, M. (2003) Inhibition of tumor angiogenesis by cannabinoids. FASEB J. 17, 529-531
18. Mestre, L., Correa, F., Docagne, F., Clemente, D., and Guaza, C. (2006) The synthetic cannabinoid WIN 55,212-2 increases COX-2 expression and PGE2 release in murine brain-derived endothelial cells following Theiler's virus infection. Biochem. Pharmacol. 72, 869-880
19. Miller, A. M., and Stella, N. (2008) CB2 receptor-mediated migration of immune cells: it can go either way. Br. J. Pharmacol. 153, 299-308
20. Stella, N. (2004) Cannabinoid signaling in glial cells. Glia 48, 267-277
21. Batkai, S., Osei-Hyiaman, D., Pan, H., El-Assal, O., Rajesh, M., Mukhopadhyay, P., Hong, F., Harvey-White, J., Jafri, A., Hasko, G., Huffman, J. W., Gao, B., Kunos, G., and Pacher, P. (2007) Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury. FASEB J. 21, 1788-1800
22. Zhang, M., Adler, M. W., Abood, M. E., Ganea, D., Jallo, J., and Tuma, R. F. (2009) CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury. Microvasc. Res. 78, 86-94
23. Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J. F., Beslot, F., Bohme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., Vassart, G., Fratta, W., and Parmentier, M. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283, 401-404
24. Buckley, N. E., McCoy, K. L., Mezey, E., Bonner, T., Zimmer, A., Felder, C. C., Glass, M., and Zimmer, A. (2000) Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur. J. Pharmacol. 396, 141-149
25. Herrmann, O., Baumann, B., De Lorenzi, R., Muhammad, S., Zhang, W., Kleesiek, J., Malfertheiner, M., Köhrmann, M., Potrovita, I., Maegele, I., Beyer, C., Burke, J. R., Hasan, M. T., Bujard, H., Wirth, T., Pasparakis, M., and Schwaninger, M. (2005) IKK mediates ischemia-induced neuronal cell death. Nat. Med. 11, 1322-1329
26. Onaivi, E. S., Ishiguro, H., Gong, J. P., Patel, S., Perchuk, A., Meozzi, P. A., Myers, L., Mora, Z., Tagliaferro, P., Gardner, E., Brusco, A., Akinshola, B. E., Liu, Q. R., Hope, B., Iwasaki, S., Arinami, T., Teasenfitz, L., and Uhl, G. R. (2006) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann. N. Y. Acad. Sci. 1074, 514-536
27. Liu, Q.-R., Pan, C. H., Hishimoto, A., Li, C. Y., Xi, Z. X., Llorente-Berzal, A., Viveros, M. P., Ishiguro, H., Arinami, T., Onaivi, E. S., and Uhl, G. R. (2009) Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands. Genes Brain Behav. 8, 519-530
28. Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., and Nishimune, Y. (1997) 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407, 313-319
29. Muhammad, S., Barakat, W., Stoyanov, S., Murikinati, S., Yang, H., Tracey, K. J., Bendszus, M., Rossetti, G., Nawroth, P., Bierhaus, A., and Schwaninger, M. (2008) The HMGB1 receptor RAGE mediates ischemic brain damage. J. Neurosci. 28, 12023-12031
30. Weston, R. M., Jones, N. M., Jarrott, B., and Callaway, J. K. (2006) Inflammatory cell infiltration after endothelin-1-induced cerebral ischemia: histochemical and myeloperoxidase correlation with temporal changes in brain injury. J. Cereb. Blood Flow Metab. 27, 100-114
31. Graff, G., Gamache, D. A., Brady, M. T., Spellman, J. M., and Yanni, J. M. (1998) Improved myeloperoxidase assay for quantitation of neutrophil influx in a rat model of endotoxininduced uveitis. J. Pharmacol. Toxicol. Meth. 39, 169-178
32. Akk, A. M., Simmons, P. M., Chan, H. W., Agapov, E., Holtzman, M. J., Grayson, M. H., and Pham, C. T. (2008) Dipeptidyl peptidase I-dependent neutrophil recruitment modulates the inflammatory response to sendai virus infection. J. Immunol. 180, 3535-3542
33. Ridder, D., Bulashevska, S., Chaitanya, G. V., Babu, P. P., Brors, B., Eils, R., Schneider, A., and Schwaninger, M. (2009) Discovery of transcriptional programs in cerebral ischemia by in silico promoter analysis. Brain Res. 1272, 3-13
34. Barone, F. C., and Feuerstein, G. Z. (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19, 819-834
35. Emerich, D. F., Dean, R. L., 3rd, and Bartus, R. T. (2002) The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct? Exp. Neurol. 173, 168-181
36. McColl, B. W., Rothwell, N. J., and Allan, S. M. (2007) Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J. Neurosci. 27, 4403-4412
37. Frangogiannis, N. G. (2007) Chemokines in ischemia and reperfusion. Thromb. Haemost. 97, 738-747
38. Andrew, D. P., Spellberg, J. P., Takimoto, H., Schmits, R., Mak, T. W., and Zukowski, M. M. (1998) Transendothelial migration and trafficking of leukocytes in LFA-1-deficient mice. Eur. J. Immunol. 28, 1959-1969
39. Prado, G. N., Suzuki, H., Wilkinson, N., Cousins, B., and Navarro, J. (1996) Role of the C terminus of the interleukin 8 receptor in signal transduction and internalization. J. Biol. Chem. 271, 19186-19190
40. Heit, B., Robbins, S. M., Downey, C. M., Guan, Z., Colarusso, P., Miller, B. J., Jirik, F. R., and Kubes, P. (2008) PTEN functions to "prioritize" chemotactic cues and prevent "distraction" in migrating neutrophils. Nat. Immunol. 9, 743-752
41. Heit, B., Tavener, S., Raharjo, E., and Kubes, P. (2002) An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J. Cell Biol. 159, 91-102
42. Chen, H., Chopp, M., Zhang, R. L., Bodzin, G., Chen, Q., Rusche, J. R., and Todd, R. F. 3rd (1994) Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann. Neurol. 35, 458-463
43. Connolly, E. S., Jr., Winfree, C. J., Springer, T. A., Naka, Y., Liao, H., Yan, S. D., Stern, D. M., Solomon, R. A., Gutierrez-Ramos, J. C., and Pinsky, D. J. (1996) Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 97, 209-216
44. Dawson, D. A., Ruetzler, C. A., Carlos, T. M., Kochanek, P. M., and Hallenbeck, J. M. (1996) Polymorphonuclear leukocytes and microcirculatory perfusion in acute stroke in the SHR. Keio J. Med. 45, 248-252; discussion 252-243
45. Arumugam, T. V., Salter, J. W., Chidlow, J. H., Ballantyne, C. M., Kevil, C. G., and Granger, D. N. (2004) Contributions of LFA-1 and Mac-1 to brain injury and microvascular dysfunction induced by transient middle cerebral artery occlusion. Am. J. Physiol. Heart Circ. Physiol. 287, H2555-2560
46. Montecucco, F., Lenglet, S., Braunersreuther, V., Burger, F., Pelli, G., Bertolotto, M., Mach, F., and Steffens, S. (2009) CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion. J. Mol. Cell. Cardiol. 46, 612-620
47. Defer, N., Wan, J., Souktani, R., Escoubet, B., Perier, M., Caramelle, P., Manin, S., Deveaux, V., Bourin, M.-C., Zimmer, A., Lotersztajn, S., Pecker, F., and Pavoine, C. (2009) The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion- induced cardiomyopathy. FASEB J. 23, 2120-2130
48. Zhang, M., Martin, B. R., Adler, M. W., Razdan, R. K., Ganea, D., and Tuma, R. F. (2008) Modulation of the balance between cannabinoid CB1 and CB2 receptor activation during cerebral ischemic/reperfusion injury. Neuroscience 152, 753-760
49. Huffman, J. W., Liddle, J., Yu, S., Aung, M. M., Abood, M. E., Wiley, J. L., and Martin, B. R. (1999) 3-(1′,1′-Dimethylbutyl)-1-deoxy-8-THC and related compounds: synthesis of selective ligands for the CB2 receptor. Bioorg. Med. Chem. 7, 2905-2914
50. Yamamoto, W., Mikami, T., and Iwamura, H. (2008) Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain. Eur. J. Pharmacol. 583, 56-61
51. Markt, P., Feldmann, C., Rollinger, J. M., Raduner, S., Schuster, D., Kirchmair, J., Distinto, S., Spitzer, G. M., Wolber, G., Laggner, C., Altmann, K.-H., Langer, T., and Gertsch, J. r. (2009) Discovery of novel cb2 receptor ligands by a pharmacophore-based virtual screening workflow. J. Med. Chem. 52, 369-378
52. Docagne, F., Muneton, V., Clemente, D., Ali, C., Loria, F., Correa, F., Hernangomez, M., Mestre, L., Vivien, D., and Guaza, C. (2007) Excitotoxicity in a chronic model of multiple sclerosis: neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation. Mol. Cell. Neurosci. 34, 551-561
53. Fernandez-Lopez, D., Martinez-Orgado, J., Nunez, E., Romero, J., Lorenzo, P., Moro, M. A., and Lizasoain, I. (2006) Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats. Pediatr. Res. 60, 169-173
54. Eljaschewitsch, E., Witting, A., Mawrin, C., Lee, T., Schmidt, P. M., Wolf, S., Hoertnagl, H., Raine, C. S., Schneider-Stock, R., Nitsch, R., and Ullrich, O. (2006) The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49, 67-79
55. Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.-K., Mack, M., Heikenwalder, M., Bruck, W., Priller, J., and Prinz, M. (2007) Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat. Neurosci. 10, 1544-1553
56. Khan, A. I., Heit, B., Andonegui, G., Colarusso, P., and Kubes, P. (2005) Lipopolysaccharide: a p38 MAPK-dependent disrupter of neutrophil chemotaxis. Microcirculation 12, 421-432
57. Tschop, J., Kasten, K. R., Nogueiras, R., Goetzman, H. S., Cave, C. M., England, L. G., Dattilo, J., Lentsch, A. B., Tschop, M. H., and Caldwell, C. C. (2009) The cannabinoid receptor 2 is critical for the host response to sepsis. J. Immunol. 183, 499-505
58. Katzan, I. L., Cebul, R. D., Husak, S. H., Dawson, N. V., and Baker, D. W. (2003) The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 60, 620-625
59. Chamorro, A., Urra, X., and Planas, A. M. (2007) Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 38, 1097-1103
60. Schabitz, W. R., Giuffrida, A., Berger, C., Aschoff, A., Schwaninger, M., Schwab, S., and Piomelli, D. (2002) Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. Stroke 33, 2112-2114
61. Zhang, R. L., Chopp, M., Jiang, N., Tang, W. X., Prostak, J., Manning, A. M., and Anderson, D. C. (1995) Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 26, 1438-1443
62. Kataoka, H., Kim, S.-W., and Plesnila, N. (2004) Leukocyte-endothelium interactions during permanent focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 24, 668-676
63. Villa, P., Triulzi, S., Cavalieri, B., Di Bitondo, R., Bertini, R., Barbera, S., Bigini, P., Mennini, T., Gelosa, P., Tremoli, E., Sironi, L., and Ghezzi, P. (2007) The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats. Mol. Med. 13, 125-133
64. Furuya, K., Takeda, H., Azhar, S., McCarron, R. M., Chen, Y., Ruetzler, C. A., Wolcott, K. M., DeGraba, T. J., Rothlein, R., Hugli, T. E., del Zoppo, G. J., and Hallenbeck, J. M. (2001) Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study. Stroke 32, 2665-2674